CS47192A3 - Keto acids with a quinoline radical and pharmaceuticals based thereon - Google Patents
Keto acids with a quinoline radical and pharmaceuticals based thereon Download PDFInfo
- Publication number
- CS47192A3 CS47192A3 CS92471A CS47192A CS47192A3 CS 47192 A3 CS47192 A3 CS 47192A3 CS 92471 A CS92471 A CS 92471A CS 47192 A CS47192 A CS 47192A CS 47192 A3 CS47192 A3 CS 47192A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- solution
- compounds
- compound
- mmol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65893191A | 1991-02-21 | 1991-02-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS47192A3 true CS47192A3 (en) | 1992-10-14 |
Family
ID=24643302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS92471A CS47192A3 (en) | 1991-02-21 | 1992-02-18 | Keto acids with a quinoline radical and pharmaceuticals based thereon |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0500360B1 (de) |
| JP (1) | JPH0788361B2 (de) |
| KR (1) | KR920016423A (de) |
| CN (1) | CN1065062A (de) |
| AT (1) | ATE154801T1 (de) |
| AU (1) | AU648385B2 (de) |
| CA (1) | CA2061675C (de) |
| CS (1) | CS47192A3 (de) |
| DE (1) | DE69220517T2 (de) |
| ES (1) | ES2104821T3 (de) |
| FI (1) | FI920734A (de) |
| HU (1) | HU9200552D0 (de) |
| IE (1) | IE920499A1 (de) |
| IL (1) | IL100985A0 (de) |
| MX (1) | MX9200714A (de) |
| NO (1) | NO920681L (de) |
| ZA (1) | ZA921232B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5270324A (en) * | 1992-04-10 | 1993-12-14 | Merck Frosst Canada, Inc. | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
| GB9216768D0 (en) * | 1992-08-07 | 1992-09-23 | Leo Pharm Prod Ltd | Chemical compounds |
| EP0830133A1 (de) * | 1995-04-28 | 1998-03-25 | Takeda Chemical Industries, Ltd. | Therapeutische zusammensetzung für arthritis |
| WO1998008820A1 (fr) * | 1996-08-26 | 1998-03-05 | Yamanouchi Pharmaceutical Co., Ltd. | Composes de benzenesulfone et sels de ces derniers |
| AU742237B2 (en) * | 1998-07-14 | 2001-12-20 | Alcon Manufacturing Limited | Use of 11-(3-dimenthylaminopropylidene)-6,11-dihydrodibenz (B,E)oxepin-2-acetic acid for the manufacture of medicament for treating non-allergic opthalmic inflammatory disorders and for the prevention of ocular neovascularization |
| DE602005015174D1 (de) | 2004-04-21 | 2009-08-13 | Teva Pharma | Verfahren zur herstellung von montelukast-natrium |
| ITMI20050247A1 (it) | 2005-02-18 | 2006-08-19 | Chemi Spa | Processo per la preparazione di montelukast |
| WO2006131782A1 (en) * | 2005-06-07 | 2006-12-14 | Glade Organics Private Limited | Process for the manufacture of methyl-2-(3-(2-(7-chloro-2-quinolinyl-ethenyl)-phenyl)-3-oxopropyl) benzoate |
| CA2608369A1 (en) | 2005-07-05 | 2007-01-11 | Teva Pharmaceutical Industries Ltd. | Purification of montelukast |
| CN101356158B (zh) * | 2005-11-18 | 2011-12-14 | 斯索恩有限公司 | 用于制备孟鲁司特的中间体及相关的化合物 |
| AR057909A1 (es) * | 2005-11-18 | 2007-12-26 | Synthon Bv | Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico. |
| WO2008032099A2 (en) * | 2006-09-15 | 2008-03-20 | Cipla Limited | Process for the preparation of montelukast, and intermediates therefor |
| ES2320077B1 (es) * | 2007-07-31 | 2010-02-26 | Moehs Iberica, S.L. | Proceso de preparacion de un antagonista de leucotrienos y de un intermedio del mismo. |
| CN101851196B (zh) * | 2010-05-28 | 2011-07-27 | 中国科学院昆明植物研究所 | 2-(1h)喹啉酮衍生物,其药物组合物及其制备方法和用途 |
| JP6038914B2 (ja) * | 2011-07-26 | 2016-12-07 | スン プハルマ アドバンセド リサーチ カンパニー リミテド | キノリン−、キノキサリン、又はベンゾチアゾールベースのシステイニルロイコトリエンアンタゴニスト（ｌｔｃ４） |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE59889B1 (en) * | 1986-02-14 | 1994-04-20 | Merck Frosst Canada Inc | 2-substituted quinoline dioic acids |
| IL88433A0 (en) * | 1987-11-25 | 1989-06-30 | Merck Frosst Canada Inc | Diarylstyrylquinoline diacids and pharmaceutical compositions containing them |
| EP0349062A1 (de) * | 1988-06-27 | 1990-01-03 | Merck Frosst Canada Inc. | Chinolinetheralkansäuren |
| NZ233752A (en) * | 1989-05-24 | 1993-05-26 | Merck Frosst Canada Inc | Substituted quinoline derivatives, preparation and pharmaceutical compositions thereof |
-
1992
- 1992-02-17 IE IE049992A patent/IE920499A1/en not_active Application Discontinuation
- 1992-02-18 IL IL100985A patent/IL100985A0/xx unknown
- 1992-02-18 CS CS92471A patent/CS47192A3/cs unknown
- 1992-02-20 DE DE69220517T patent/DE69220517T2/de not_active Expired - Fee Related
- 1992-02-20 AU AU11119/92A patent/AU648385B2/en not_active Ceased
- 1992-02-20 AT AT92301393T patent/ATE154801T1/de not_active IP Right Cessation
- 1992-02-20 EP EP92301393A patent/EP0500360B1/de not_active Expired - Lifetime
- 1992-02-20 FI FI920734A patent/FI920734A/fi not_active Application Discontinuation
- 1992-02-20 KR KR1019920002536A patent/KR920016423A/ko not_active Application Discontinuation
- 1992-02-20 HU HU9200552A patent/HU9200552D0/hu unknown
- 1992-02-20 MX MX9200714A patent/MX9200714A/es unknown
- 1992-02-20 ES ES92301393T patent/ES2104821T3/es not_active Expired - Lifetime
- 1992-02-20 NO NO92920681A patent/NO920681L/no unknown
- 1992-02-20 CN CN92102076A patent/CN1065062A/zh active Pending
- 1992-02-20 ZA ZA921232A patent/ZA921232B/xx unknown
- 1992-02-21 CA CA002061675A patent/CA2061675C/en not_active Expired - Fee Related
- 1992-02-21 JP JP4034632A patent/JPH0788361B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NO920681L (no) | 1992-08-24 |
| DE69220517D1 (de) | 1997-07-31 |
| IL100985A0 (en) | 1992-11-15 |
| ZA921232B (en) | 1992-10-28 |
| HU9200552D0 (en) | 1992-05-28 |
| CA2061675A1 (en) | 1992-08-22 |
| AU648385B2 (en) | 1994-04-21 |
| EP0500360B1 (de) | 1997-06-25 |
| DE69220517T2 (de) | 1997-12-18 |
| FI920734A0 (fi) | 1992-02-20 |
| NO920681D0 (no) | 1992-02-20 |
| CA2061675C (en) | 2002-12-17 |
| FI920734A (fi) | 1992-08-22 |
| AU1111992A (en) | 1992-08-27 |
| JPH0525135A (ja) | 1993-02-02 |
| CN1065062A (zh) | 1992-10-07 |
| ATE154801T1 (de) | 1997-07-15 |
| KR920016423A (ko) | 1992-09-24 |
| EP0500360A1 (de) | 1992-08-26 |
| ES2104821T3 (es) | 1997-10-16 |
| JPH0788361B2 (ja) | 1995-09-27 |
| MX9200714A (es) | 1992-10-01 |
| IE920499A1 (en) | 1992-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1333714C (en) | Quinoline ether alkanoic acids for use as inhibitors of leukotriene biosynthesis | |
| AU653476B2 (en) | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists | |
| US5952347A (en) | Quinoline leukotriene antagonists | |
| US5428033A (en) | Saturated hydroxyalkylquinoline acids as leukotriene antagonists | |
| CA2079376C (en) | (bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis | |
| CA2079374C (en) | (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis | |
| WO1993025546A1 (en) | Bicyclic(azaaromatic)indoles as inhibitors of leukotriene biosynthesis | |
| EP0535926A1 (de) | (Hetero-Arylmethoxy)indole als Inhibitore der leukotriene Biosynthese | |
| EP0535923A1 (de) | (Azaarylmethoxy)indole als Inhibitore der Leukotriene Biosynthese | |
| CS47192A3 (en) | Keto acids with a quinoline radical and pharmaceuticals based thereon | |
| AU684884B2 (en) | Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists | |
| US5266568A (en) | Hydroxyalkylquinoline ether acids as leukotriene antagonists | |
| WO1994011378A1 (en) | ARYL THIOPYRANO[2,3,4-c,d]INDOLES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS | |
| WO1993021168A1 (en) | Thiazole-substituted benzyl alcohols as leukotriene antagonists | |
| EP0480708B1 (de) | Hydroxyalkylchinolin Äther Säure als Leukotrien-Antagoniste | |
| US5149703A (en) | Quinoline-substituted chromans and related compounds as leukotriene antagonists | |
| US5438141A (en) | Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists | |
| AU708126B2 (en) | Heteroaryl diol acids as leukotriene antagonists | |
| US5334597A (en) | Indole carbamates as leukotriene antagonists | |
| US5350760A (en) | Aza-5,5-fused hetrocyclic acids as leukotriene antagonists | |
| US5212180A (en) | Quinoline-containing ketoacids as leukotriene antagonists | |
| WO1993021169A1 (en) | Benzothiazole-substituted benzyl alcohols as leukotriene antagonists | |
| CA2223414C (en) | Heteroaryl diol acids as leukotriene antagonists |